Lv0
0 积分 2022-07-15 加入
The story of the development of generic lenalidomide: How one company thwarted the Hatch-Waxman Act to generate billions of dollars in revenue
11小时前
已完结
MCL-133 Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results From the Phase 1/2 BRUIN Study
1天前
已完结
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma
1年前
已完结
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
1年前
已完结
皖公网安备34019202002308
